Nebojša Antonijević

Author

Nebojša Antonijević

Also Known As

Dmitry Duplyakov, N Antonijevic, N Antonijević, N. Antonijevic, N. Antonijević, N. M. Antonijevic, Nebojsa Antonijevic, Nebojsa M Antonijevic, Nebojsa M. Antonijevic, Nebojsa M. Antonijević

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Belgrade Institute for Cardiovascular Diseases of Vojvodina Centar za Promociju Nauke Institute of Molecular Genetics and Genetic Engineering Institute of Molecular Genetics

About

Nebojša Antonijević is an author at University of Belgrade specializing in genetic epidemiology, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	54
2	Public Health	3	3	41
3	Biostatistics	1	1	19
4	Epidemiology	1	1	12
5	Immunology	1	1	10

Nebojša Antonijević

Publications

375

Citations

H-Index

Page 1

	Year	Citations
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention Igor Mrdović, Lidija Savić, Gordana Krljanać, Coronary Artery Disease	2011	48
[Anemia in hypothyroidism]. Nebojša Antonijević, M Nesović, Boz̆o Trbojević, PubMed	1999	43
Thrombophilia in Women with Pregnancy-Associated Complications: Fetal Loss and Pregnancy-Related Venous Thromboembolism Mirjana Kovač, Gorana Mitić, Željko Miković, Gynecologic and Obstetric Investigation	2010	34
Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention Dragan Matić, Dejan Milašinović, Milika Ašanin, Heart	2013	29
Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin Nebojša Antonijević, Nebojša Savić, Jovan Peruničić, Journal of Clinical Apheresis	2006	27
Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention Dragan Matić, Milika Ašanin, Sanja Stanković, Vojnosanitetski pregled	2014	23
Type and Location of Venous Thromboembolism in Carriers of Factor V Leiden or Prothrombin G20210A Mutation Versus Patients With No Mutation Mirjana Kovač, Gorana Mitić, Željko Miković, Clinical and Applied Thrombosis/Hemostasis	2008	21
PCR AMPLIFICATION ON WHOLE BLOOD SAMPLES TREATED WITH DIFFERENT COMMONLY USED ANTICOAGULANTS Vladimir Djordjević, Marija Stanković, Aleksandra Nikolić, Pediatric Hematology and Oncology GeneticsGenetic EpidemiologyPathologyNucleic Acid Amplification TestThrombosis	2006	19
Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention Slobodan Obradović, Jovan P. Antović, Nebojša Antonijević, Blood Coagulation & Fibrinolysis	2009	17
Economic Analysis of Pharmacogenomic-Guided Clopidogrel Treatment in Serbian Patients with Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Christina Mitropoulou, V. Fragoulakis, Ljiljana Rakićević, Pharmacogenomics	2016	17

Page 1